Article

AJMC® in the Press, June 2, 2023

Author(s):

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

An article by HealthCentral referenced a study published in the March 2016 issue of The American Journal of Managed Care®(AJMC®). The study, “Understanding Vaccination Rates and Attitudes Among Patients With Rheumatoid Arthritis,” found that patients with rheumatoid arthritis reported a moderate rate of previous pneumococcal vaccination and a very low rate of the herpes zoster vaccination.

An article by Komando referenced a contributor piece published on AJMC.com, the website of AJMC. The article, “Contributor: Medication Adherence Is Not a Zero-Sum Game,” featured a contributor speaking on mitigating the high cost of prescription drugs in addressing getting patients to take their medications as advised.

An article from Specialty Pharmacy Continuum referenced an article published on AJMC’s sister site, The Center for Biosimilars®. The article, “Part 1: Biosimilars to Bring a Bumper Crop of Adalimumab Options,” provided specifics on each of the adalimumab biosimilar products that were upcoming in 2023 and why Europe may have different experiences than that of the United States.

Related Videos
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center (UPMC)
Pierluigi Porcu, MD
Benjamin Chen, MD, PhD
4 experts are featured in this series.
5 experts are featured in this series
5 experts are featured in this series
4 experts are featured in this series.
Kimberly Westrich, MA, chief strategy officer, NPC
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo